関連する実験動画
Updated: Feb 22, 2026

10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Published on: October 17, 2019
11.7K
ACS @150:抗菌薬の発見における医薬品化学の役割
Yash Acharya1, Jayanta Haldar1,2
1Antimicrobial Research Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Jakkur, Bengaluru-560064, India.
ACS infectious diseases
|February 20, 2026
まとめ
薬剤化学は,薬剤の効能,薬剤動力学,および耐性を克服することによって,抗菌薬の発見を大幅に進めてきました. この分野は進化し続け,将来の治療開発のための新しいパラダイムを探求しています.
科学分野:
- 薬用化学 薬用化学について
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
- 薬理学 薬理学とは
背景:
- 薬剤化学は,治療の開発,特に抗菌薬の発見において,抗生物質の時代以来,重要な役割を果たしてきました.
- 貢献には,強力なアナログを開発し,薬理動力学と安定性を改善し,薬剤耐性の克服が含まれています.
- この分野は,過去50年間にわたり,医学を経験的学科から厳格な科学へと移行させてきました.
研究 の 目的:
- 抗菌薬の開発における医薬品化学の中心的な役割を強調する.
- 抗菌薬の開発の未来に影響を与える新興パラダイムを探求する.
- アメリカ化学協会の貢献150周年を記念して.
主な方法:
- この見解は,抗菌薬の開発のための医薬品化学における歴史的貢献と将来の傾向を統合しています.
- アナログ開発,薬物動態の最適化,配方戦略の進歩をレビューしています.
- 新興パラダイムは,現在の課題の文脈で議論されます.
主要な成果:
- 薬剤化学は,抗菌薬の効能,安定性,投与量を高めるのに役立っている.
- 薬剤化学の介入を通じて抗菌剤耐性を克服するうえで,著しい進展がみられた.
- この分野の進化は,現代医学と薬物開発を大きく形作っています.
結論:
- 薬剤化学は,抗菌薬療法の進歩に中心的な役割を果たしています.
- 新興のパラダイムは,抗菌薬の発見をさらに革命的にする準備ができています.
- 医薬品化学における継続的なイノベーションは,将来の感染症の課題に対処するために不可欠です.
関連する概念動画
Drug Discovery: Overview
12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Combined Effects of Drugs: Synergism
7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.0K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Antibiotic Selection
60.5K
Overview
60.5K
Targets for Drug Action: Overview
10.7K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.7K

